| 英文名稱(chēng) | Anti-Human IL-1B Monoclonal Antibody(Canakinumab) |
|---|---|
| 中文名稱(chēng) | 卡那奴單抗 |
| CAS號(hào) | 914613-48-2 |
| 儲(chǔ)存條件 | Sealed and stored at ≤-30℃, away from light. Avoid freeze-thaw cycles |
| 規(guī)格 | 庫(kù)存 | 目錄價(jià) | 會(huì)員專(zhuān)享價(jià) | 數(shù)量 |
|---|---|---|---|---|
| 1 mg | 3-5days | ¥5000.00 | 登錄后可見(jiàn) | |
| 5 mg | 3-5days | ¥22000.00 | 登錄后可見(jiàn) | |
| 10 mg | 3-5days | ¥38000.00 | 登錄后可見(jiàn) | |
| 50 mg | 3-5days | ¥154000.00 | 登錄后可見(jiàn) | |
| 100 mg | 3-5days | ¥275000.00 | 登錄后可見(jiàn) |
| 英文名稱(chēng) | Anti-Human IL-1B Monoclonal Antibody(Canakinumab) |
|---|---|
| 中文名稱(chēng) | 卡那奴單抗 |
| CAS號(hào) | 914613-48-2 |
| 儲(chǔ)存條件 | Sealed and stored at ≤-30℃, away from light. Avoid freeze-thaw cycles |
Canakinumab (Anti-IL-1b) is a recombinant human anti-IL-1β monoclonal antibody targeting IL-1β and neutralizing IL-1β signaling. It can be used in treatment of disorders of autoimmune origin like familial mediterranean fever, mevalonate kinase deficiency, tumor necrosis factor receptor-associated periodic syndrome (TRAPS). MW :145.5 KD.